0      0

2022 ISPE Annual Meeting & Expo

SES208a - Update on the Implementation Status of ICH Q12 in Canada

Nov 1, 2022 1:45pm ‐ Nov 1, 2022 3:15pm


During this presentation, Mr. Hamel will summarize the key points associated with the implementation of ICH Q12 in Canada. He will provide highlights of the ISPE training program that was offered to all reviewers at Health Canada on ICH Q12 and will discuss the role of the Canadian CPID vs the PLCM document.


  • Hugo Hamel, Manager, Biotherapeutic Quality Division, Health Canada

You must be logged in and own this session in order to post comments.